Inventor
Meinhard Hasslacher
Inventor
Vienna, AT
Overview
Patents· 25 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Nprimary
C12NMicroorganisms or enzymes27%
C12YEnzymes23%
C07KPeptides17%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations15%
A61KPreparations for medical, dental or toiletry purposes9%
B01DSeparation3%
C12MApparatus for enzymology or microbiology3%
A61LMethods or apparatus for sterilising materials or objects in general2%
A61MDevices for introducing media into, or onto, the body2%
PatentTitleYear
11,000,561Adeno-associated virus purification methods202110,934,340Separation of VWF and VWF propeptide by chromatographic methods202110,723,761Protein purification by anion exchange chromatography202010,724,024Cell culture methods for expressing ADAMTS protein202010,378,004Protein purification by anion exchange chromatography201910,202,417Purification method for vitamin K dependent proteins by anion exchange chromatography201910,202,416Purification method for divalent cation binding proteins on anion exchange resin201910,072,254Cell culture methods for expressing ADAMTS13 protein201810,036,002Factor X activation20189,701,710'Protein purification by anion exchange chromatography'20179,670,456'Virus filtration of cell culture media'20179,662,376'Formulations of recombinant furin'20179,441,216'Cell culture medium for ADAMTS protein expression'20169,315,560'Purification of VWF for increased removal of non-lipid enveloped viruses'20169,127,265'Cell culture medium for ADAMTS protein expression'20159,127,264'Substantially animal protein-free recombinant furin and methods for producing the same'20158,945,895'Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof'20158,877,473'Formulations of recombinant furin'20148,759,026'Methods for increasing recovery of an ADAMTS activity from a cell culture supernatant'20148,399,632'Method for the purification of recombinant blood coagulation factor IX enriched in sulfated and/or phosphorylated molecules'20138,388,847'Methods of concentrating shear-sensitive biopolymers'20138,313,926'Methods for expressing ADAMTS proteins in cell culture medium supplemented with zinc'20128,148,502'R-ALPHA1 antitrypsin anion exchange chromatography'20128,143,347'Pegylation of recombinant blood coagulation factors in the presence of bound antibodies'20128,058,411'Method for producing mature VWF from VWF pro-peptide'2011Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2011–2019Patents assigned to HASSLACHER MEINHARD (11)· patent assignee history
2011–2015Patents assigned to BAXTER HEALTHCARE SA (10)· patent assignee history
2011–2015Patents assigned to BAXTER INT (10)· patent assignee history
2011–2021Based in Vienna, AT· patent location history
2015–2021Patents assigned to BAXALTA INC (15)· patent assignee history
2015–2021Patents assigned to Baxalta GmbH (15)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BAXALTA INC | 15 | 2015–2021 |
| Baxalta GmbH | 15 | 2015–2021 |
| HASSLACHER MEINHARDself | 11 | 2011–2019 |
| BAXTER HEALTHCARE SA | 10 | 2011–2015 |
| BAXTER INT | 10 | 2011–2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Vienna, AT | 25 | 2011–2021 |